In this study, nuclear HDAC6 could interact with and deacetylate NF-κB to reduce the DNA-binding activity of NF-κB on the MMP2 promoter in NSCLC cells, which reduced the expressions of MMP2 transcript and protein. The gene discussed is HDAC6; the disease is non-small cell lung carcinoma.